Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease

被引：0
|
作者：
Georgantas, Robert W. [1 ]
Bohana-Kashtan, Osnat [1 ]
Civin, Curt I. [1 ,2 ]
机构：
[1] Johns Hopkins, Div Immunol & Hematopoiesis, Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.1137
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1041
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [41] Infusion of Ex Vivo Activated Donor Type 2 Innate Lymphoid Cells Inhibit Th1 Activity and Reduces Acute Graft-Versus-Host Disease
    Bruce, Danny
    West, Michelle
    Dant, Trisha A.
    Panoskaltsis-Mortari, Angela
    Blazar, Bruce R.
    Coghill, James M.
    Serody, Jonathan S.
    BLOOD, 2014, 124 (21)
  • [42] Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
    Alfonso Rodríguez-Gil
    Virginia Escamilla-Gómez
    Melanie Nufer
    Félix Andújar-Sánchez
    Teresa Lopes-Ramos
    José Antonio Bejarano-García
    Estefanía García-Guerrero
    Cristina Calderón-Cabrera
    Teresa Caballero-Velázquez
    Clara Beatriz García-Calderón
    Paola Hernández-Díaz
    Juan Luis Reguera-Ortega
    Nancy Rodríguez-Torres
    Nuria Martínez-Cibrián
    José Ignacio Rodríguez-Barbosa
    Javier Villadiego
    José Antonio Pérez-Simón
    Scientific Reports, 12
  • [43] Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib
    Rodriguez-Gil, Alfonso
    Escamilla-Gomez, Virginia
    Nufer, Melanie
    Andujar-Sanchez, Felix
    Lopes-Ramos, Teresa
    Antonio Bejarano-Garcia, Jose
    Garcia-Guerrero, Estefania
    Calderon-Cabrera, Cristina
    Caballero-Velazquez, Teresa
    Beatriz Garcia-Calderon, Clara
    Hernandez-Diaz, Paola
    Luis Reguera-Ortega, Juan
    Rodriguez-Torres, Nancy
    Martinez-Cibrian, Nuria
    Ignacio Rodriguez-Barbosa, Jose
    Villadiego, Javier
    Antonio Perez-Simon, Jose
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [44] GRAFT VERSUS HOST DISEASE IN RATS AFTER DONOR TREATMENT WITH CYCLOPHOSPHAMIDE AND SPLEEN-CELLS OF HOST ORIGIN
    FINK, MP
    CLOUD, CL
    TRANSPLANTATION, 1974, 17 (05) : 508 - 512
  • [45] Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease
    Maeda, Y
    Levy, RB
    Reddy, P
    Liu, C
    Clouthier, SG
    Teshima, F
    Ferrara, JLM
    BLOOD, 2005, 105 (05) : 2023 - 2027
  • [46] Mesenchymal stem cells for treatment of severe acute graft-versus-host disease
    Ringden, O
    Uzunel, M
    Rasmusson, I
    Remberger, ME
    Sundberg, B
    Lonnies, H
    Marschall, HU
    Dlugosz, A
    Szakos, A
    Hassan, Z
    Omazic, B
    Aschan, J
    Barkholt, L
    Le Blanc, K
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 2 - 2
  • [47] Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment
    Kuzmina, L. A.
    Petinati, N. A.
    Vasilieva, V. A.
    Dovydenko, M., V
    Drokov, M. Yu
    Davydova, Yu O.
    Kapranov, N. M.
    Sats, N., V
    Chabaeva, Yu A.
    Kulikov, S. M.
    Gaponova, T., V
    Drize, N., I
    Parovichnikova, E. N.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (07) : 23 - 30
  • [48] Treatment of acute graft versus host disease with mesancyhmal stem cells: Questions and answers
    Bozdag, Sinem Civriz
    Tekgunduz, Emre
    Altuntas, Fevzi
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (01) : 71 - 75
  • [49] Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells
    Resnick, Igor B., Jr.
    Stepensky, Polina
    Shapira, Michael Y.
    Barkatz, Claudine
    Elkin, Gregory
    Gurevich, Olga
    Shimoni, Avichai
    Varda-Bloom, Nira
    Yeshurun, Moshe
    Toren, Amos, Sr.
    Zukerman, Tsila
    Weintraub, Michael, Sr.
    Nagler, Arnon
    Or, Reuven
    BLOOD, 2009, 114 (22) : 886 - 887
  • [50] Mesenchymal stem cells for treatment of severe acute graft-versus-host disease
    Le Blanc, K.
    Frassoni, F.
    Ball, L.
    Locatelli, F.
    Lewis, I.
    Lanino, E.
    Sundberg, B.
    Roelofs, H.
    Lonnies, L.
    Dini, G.
    Bacigalupo, A.
    Fibbe, W.
    Ringden, O.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S27 - S27
12345